University of Wisconsin
University of Wisconsin
Madison, Wisconsin, United States10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-10-01 | NCT07102381 | |
| The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT05836987 | |
| Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07766187 | |
| Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Not yet recruiting | Early phase 1 | 2026-09-29 | NCT07218653 | |
| A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device | Aneurysm, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Not applicable | 2026-09-17 | NCT02098265 | |
| First Responder Aphasia Strategy Training | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aphasia, communication disorder, language disorder, nervous system disorder, speech disorder | Enrolling by invitation | Not applicable | 2026-09-11 | NCT06678854 | |
| COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Status Epilepticus, febrile infection-related epilepsy syndrome, nervous system disorder, new-onset refractory status epilepticus, visual epilepsy | Not yet recruiting | Phase 3 | 2026-08-19 | NCT07281027 | |
| Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors | prostate adenocarcinoma | Active, not recruiting | Phase 2 | 2026-08-12 | NCT04126070 | |
| Optimizing Smart Technology for Addiction Recovery | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-06-25 | NCT07573540 | |
| Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia | Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not applicable | 2026-04-03 | NCT06921993 |